Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04193475 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Machine Learning in Quantitative Stress Echocardiography

Study acronym: MLQSE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion date changed from estimate of Aug 13, 2025 to Aug 1, 2021
    • Study completion date: Aug 30, 2025 to Mar 1, 2026
    v7
  2. Notable Primary completion date: Aug 13, 2023 to Aug 13, 2025
    • Study completion date: Aug 30, 2023 to Aug 30, 2025
    v6
  3. Minor Primary completion date: Jun 13, 2023 to Aug 13, 2023
    • Study completion date: Jun 30, 2023 to Aug 30, 2023
    v5
  4. Minor Re-verified, no change to tracked fieldsv4
  5. Notable Primary completion date: May 2021 to Jun 13, 2023
    • Study completion date: Jun 2023 to Jun 30, 2023
    v3
  6. Minor Secondary endpoints: 3 to 4
    • Study description shortened, about 7 words
    v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Greater diagnostic accuracy is required to find out who is at risk of a heart attack as this can reduce the requirement of more invasive downstream tests and thereby improve the patient experience and also reduce their exposure to risk. Stress echocardiography is a routine clinical test that involves using ultrasound to image the heart whilst it is under stress to assess the risk of a heart attack. This study will focus on developing more accurate analysis tools to interpret the results of these stress echocardiographic scans. New methods will be tested to measure the function of each part of the heart muscle, using advanced analysis of the information obtained when high-frequency sound waves are bounced off the heart inside the chest. The researchers will measure and report exact heart function during stress, so that they will be able to recognise normal hearts and those with any disease. New computer methods will be developed to display any abnormality, which will make it easier for doctors to choose the best treatment for patients who are at risk. The goals and potential benefits of this research proposal are to update the interpretation of a routinely used clinical test (stress echocardiography) to produce a reliable new method for diagnosing the precise effects of diseased arteries on the function of the heart muscle; to develop new computer graphics that adapt to show individual risks for each patient; and to implement new computer models that can be constantly updated
Trial Details
NCT Number NCT04193475
Lead Sponsor Hull University Teaching Hospitals NHS Trust
Collaborators: Barts & The London NHS Trust, Cardiff and Vale University Health Board
Conditions
(from sponsor)
Cardiovascular Diseases, Ischaemic Heart Disease
Related terms Angina Pectoris, Cardiovascular Diseases, Chest Pain, Coronary Artery Disease, Sprains and Strains
Enrollment 1,250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov